MedTrace Logo

Circulating IL-6, Clusterin and Irisin in Obese Subjects

NCT04133896 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 176

Last updated 2019-10-22

No results posted yet for this study

Summary

evaluate the circulating levels of IL-6, clusterin and irisin in obese subjects of both sexes who had different classes of obesity and their sexual dimorphism also identify the association of IL-6, clusterin and irisin with insulin resistance.

Conditions

Interventions

DIAGNOSTIC_TEST

IL-6, Clusterin, Irisin Level

Blood samples to determine levels of Circulating IL-6, Clusterin and Irisin

Sponsors & Collaborators

  • Tanta University

    collaborator OTHER

  • Rehab Werida

    lead OTHER

Principal Investigators

  • Rehab H Werida, Lecturer · Damanhour University, Faculty of Pharmacy

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-01
Primary Completion
2019-06-01
Completion
2019-06-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04133896 on ClinicalTrials.gov